The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease

C Huang, H Chu, Y Ma, Z Zhou, C Dai, X Huang… - Brain stimulation, 2019 - Elsevier
Background Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …
被引用次数：34 相关文章

The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease.

C Huang, H Chu, Y Ma, Z Zhou, C Dai, X Huang… - Brain …, 2018 - europepmc.org
Background Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …

The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease

C Huang, H Chu, Y Ma, Z Zhou, C Dai, X Huang… - Brain …, 2019 - hero.epa.gov
BACKGROUND: Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …

The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease

C Huang, H Chu, Y Ma, Z Zhou, C Dai… - Brain …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …

The neuroprotective effect of deep brain stimulation at nucleus basalis of Meynert in transgenic mice with Alzheimer's disease

C Huang, H Chu, Y Ma, Z Zhou, C Dai… - … Clinical Research in …, 2019 - brainstimjrnl.com
Background Alzheimer's disease (AD) is the most common type of dementia and mainly
treated by drugs, while the therapeutic outcomes are very limited. This study aimed to …